Last Updated: November 8, 2026

Avyxa Holdings Company Profile

« Back to Dashboard

What is the competitive landscape for AVYXA HOLDINGS

AVYXA HOLDINGS has twelve approved drugs.

There are six US patents protecting AVYXA HOLDINGS drugs.

Summary for Avyxa Holdings

US Patents:	6
Tradenames:	12
Ingredients:	12
NDAs:	12

Drugs and US Patents for Avyxa Holdings

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Avyxa Holdings	KYXATA	carboplatin	SOLUTION;INTRAVENOUS	219921-003	Aug 8, 2025		RX	Yes	Yes	12,427,104	⤷ Start Trial	Y			⤷ Start Trial
Avyxa Holdings	FRINDOVYX	cyclophosphamide	SOLUTION;INTRAVENOUS	210852-003	Jun 7, 2023		RX	Yes	Yes	11,382,923	⤷ Start Trial	Y			⤷ Start Trial
Avyxa Holdings	VYKOURA	leucovorin calcium	SOLUTION;INTRAMUSCULAR, INTRAVENOUS	220406-003	Feb 3, 2026		RX	Yes	Yes	12,564,592	⤷ Start Trial	Y			⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for Avyxa Holdings Drugs

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
China	111714449	⤷ Start Trial
Japan	2018512395	⤷ Start Trial
China	111728941	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Supplementary Protection Certificates for Avyxa Holdings Drugs

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0138504	2004C/004	Belgium	⤷ Start Trial	PRODUCT NAME: FULVESTRANT; REGISTRATION NO/DATE: EU/1/03/269/001 20040311
2785706	122020000046	Germany	⤷ Start Trial	PRODUCT NAME: FOSNETUPITANT MIT PALONOSETRON; REGISTRATION NO/DATE: C(2020)1804(FINAL) 20200316
0430190	SPC/GB05/032	United Kingdom	⤷ Start Trial	PRODUCT NAME: PALONOSETRON OR AN ISOMER, MIXTURE OF ISOMERS, N-OXIDE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/04/306/001 20050322
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Avyxa Holdings

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.